Literature DB >> 18416966

In vitro effects of preservatives in nasal sprays on human nasal epithelial cells.

Ching-Yin Ho1, Meng-Chuan Wu, Ming-Ying Lan, Ching-Ting Tan, An-Hang Yang.   

Abstract

BACKGROUND: The preservatives benzalkonium chloride and potassium sorbate are widely used in nasal drops and sprays. Recently, side effects resulting from mucosal damage caused by benzalkonium chloride and potassium sorbate were reported.
METHODS: We investigated the toxicity of benzalkonium chloride and potassium sorbate on human nasal epithelial cells in vitro. Using primary human nasal epithelial cells, different concentrations of benzalkonium chloride, potassium sorbate, or phosphate-buffered saline (PBS; control group) solutions were cocultured with nasal epithelial cells for 15 minutes. Then, the viability of the cells and the cell morphology were assessed.
RESULTS: Nasal epithelial cells were more severely damaged with use of clinical preparations or higher concentrations of benzalkonium chloride than in the control group. In addition, nasal epithelial cell membrane lysis was seen on electronic microscopy in the benzalkonium chloride groups. In contrast, there was no significant cell damage seen in the potassium sorbate groups compared with the control group, even with higher concentrations than clinically used.
CONCLUSION: Potassium sorbate appears to be a relatively safer preservative than benzalkonium chloride for use in nasal sprays and drops in vitro study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18416966     DOI: 10.2500/ajr.2008.22.3154

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  7 in total

Review 1.  Advances in metered dose inhaler technology: hardware development.

Authors:  Stephen W Stein; Poonam Sheth; P David Hodson; Paul B Myrdal
Journal:  AAPS PharmSciTech       Date:  2013-12-20       Impact factor: 3.246

2.  NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption.

Authors:  Wooseong Kim; Nico Fricke; Annie L Conery; Beth Burgwyn Fuchs; Rajmohan Rajamuthiah; Elamparithi Jayamani; Petia M Vlahovska; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-02-24       Impact factor: 3.808

3.  Development of Optimized Sumatriptan-Prochlorperazine Combined Orodispersible Films Without Disintegrant: in vitro, ex vivo and in vivo Characterization.

Authors:  Sana Javed; Amjad Hussain; Pervaiz Akhtar Shah; Syed Atif Raza; Ubaid Ullah Anwer; Rahat Shamim; Fatima Rasool; Muhammad Ahsan Hafiz; Nadeem Irfan Bukhari
Journal:  AAPS PharmSciTech       Date:  2022-06-02       Impact factor: 3.246

4.  Short-Term Pulmonary Toxicity Assessment of Pre- and Post-incinerated Organomodified Nanoclay in Mice.

Authors:  Todd A Stueckle; Donna C Davidson; Ray Derk; Tiffany G Kornberg; Lori Battelli; Sherri Friend; Marlene Orandle; Alixandra Wagner; Cerasela Zoica Dinu; Konstantinos A Sierros; Sushant Agarwal; Rakesh K Gupta; Yon Rojanasakul; Dale W Porter; Liying Rojanasakul
Journal:  ACS Nano       Date:  2018-02-22       Impact factor: 15.881

5.  Enhanced Biofilm Eradication and Reduced Cytotoxicity of a Novel Polygalacturonic and Caprylic Acid Wound Ointment Compared with Common Antiseptic Ointments.

Authors:  Bahgat Z Gerges; Joel Rosenblatt; Y-Lan Truong; Ruth A Reitzel; Ray Hachem; Issam I Raad
Journal:  Biomed Res Int       Date:  2021-02-25       Impact factor: 3.411

6.  Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2.

Authors:  Richard J A Moakes; Scott P Davies; Zania Stamataki; Liam M Grover
Journal:  Adv Mater       Date:  2021-05-31       Impact factor: 32.086

7.  In Vitro Evaluation of Curcumin- and Quercetin-Loaded Nanoemulsions for Intranasal Administration: Effect of Surface Charge and Viscosity.

Authors:  Gustavo Vaz; Adryana Clementino; Evgenia Mitsou; Elena Ferrari; Francesca Buttini; Cristina Sissa; Aristotelis Xenakis; Fabio Sonvico; Cristiana Lima Dora
Journal:  Pharmaceutics       Date:  2022-01-14       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.